Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response
- PMID: 21996700
- PMCID: PMC3192549
- DOI: 10.1093/infdis/jir451
Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response
Abstract
Latent Mycobacterium tuberculosis infection (LTBI) and active tuberculosis (TB) are 2 ends of a spectrum of states ranging from asymptomatic infection to overt disease. While progressing from LTBI to TB, patients often undergo asymptomatic states with detectable manifestations indicative of disease. Such asymptomatic disease states frequently remain undiagnosed, and their manifestations and duration are mostly dependent on host immune response. Various terms referring to such states are used in the literature, often interchangeably and without explicit definitions. Defining these intermediate states in concrete terms is important for pragmatic reasons, as they might impact upon the diagnostic performance of TB biomarkers and could also present targets for therapeutic interventions. We here propose definitions for 2 commonly used terms, "incipient" and "subclinical" TB, to describe asymptomatic disease states occurring at opposite ends of the host response spectrum. We propose using the term "incipient TB" when referring to early, contained disease in asymptomatic, relatively immunocompetent persons. In contrast, we propose using the term "subclinical TB" to refer to disease in asymptomatic, immunocompromised individuals in whom it is largely associated with loss of effective containment. The rationale for this article is to facilitate the discussion of such early disease states, especially in relation to their impact on TB biomarker discovery and assessment of new diagnostics, and with regard to treatment decisions and ultimately outcome.
Figures
Comment in
-
Immunological evidence of incipient pulmonary tuberculosis.J Infect Dis. 2012 Nov 15;206(10):1630-1; author reply 1631-2. doi: 10.1093/infdis/jis557. Epub 2012 Sep 10. J Infect Dis. 2012. PMID: 22966117 No abstract available.
Similar articles
-
Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.Scand J Immunol. 2016 Dec;84(6):344-352. doi: 10.1111/sji.12493. Scand J Immunol. 2016. PMID: 27636597
-
New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease.Int J Tuberc Lung Dis. 2023 Jul 1;27(7):499-505. doi: 10.5588/ijtld.23.0032. Int J Tuberc Lung Dis. 2023. PMID: 37353874
-
Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.BMC Infect Dis. 2018 Mar 16;18(1):133. doi: 10.1186/s12879-018-3007-y. BMC Infect Dis. 2018. PMID: 29548281 Free PMC article.
-
Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.Clin Microbiol Rev. 2018 Jul 18;31(4):e00021-18. doi: 10.1128/CMR.00021-18. Print 2018 Oct. Clin Microbiol Rev. 2018. PMID: 30021818 Free PMC article. Review.
-
Latent tuberculosis infection--Revisiting and revising concepts.Tuberculosis (Edinb). 2015 Jul;95(4):373-84. doi: 10.1016/j.tube.2015.04.003. Epub 2015 May 15. Tuberculosis (Edinb). 2015. PMID: 26038289 Review.
Cited by
-
Feasibility of novel approaches to detect viable Mycobacterium tuberculosis within the spectrum of the tuberculosis disease.Front Med (Lausanne). 2022 Aug 22;9:965359. doi: 10.3389/fmed.2022.965359. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36072954 Free PMC article. Review.
-
Factors Associated With Sputum Culture-Negative vs Culture-Positive Diagnosis of Pulmonary Tuberculosis.JAMA Netw Open. 2019 Feb 1;2(2):e187617. doi: 10.1001/jamanetworkopen.2018.7617. JAMA Netw Open. 2019. PMID: 30735231 Free PMC article.
-
Antibody-mediated immunity against tuberculosis: implications for vaccine development.Cell Host Microbe. 2013 Mar 13;13(3):250-62. doi: 10.1016/j.chom.2013.02.009. Cell Host Microbe. 2013. PMID: 23498951 Free PMC article. Review.
-
Framing the detection of incipient tuberculosis infection: A qualitative study of political prioritisation.Trop Med Int Health. 2022 Apr;27(4):445-453. doi: 10.1111/tmi.13734. Epub 2022 Feb 22. Trop Med Int Health. 2022. PMID: 35156273 Free PMC article.
-
Comparative immune responses to Mycobacterium tuberculosis in people with latent infection or sterilizing protection.iScience. 2023 Jul 20;26(8):107425. doi: 10.1016/j.isci.2023.107425. eCollection 2023 Aug 18. iScience. 2023. PMID: 37564701 Free PMC article.
References
-
- World Health Organization. Tuberculosis fact sheet 104. Geneva, Switzerland: WHO; 2010. http://www.who.int/mediacentre/factsheets/fs104/en/index.html. Accessed 3 February 2011.
-
- Corbett EL, Charalambous S, Moloi VM, et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med. 2004;170:673–9. - PubMed
-
- Mtei L, Matee M, Herfort O, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis. 2005;40:1500–7. - PubMed
-
- Cardona PJ. Revisiting the natural history of tuberculosis: the inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Arch Immunol Ther Exp (Warsz) 2010;58:7–14. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources